GlobeStar Therapeutics Corp Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GlobeStar Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • GlobeStar Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $42.8K, a 5.68% increase year-over-year.
  • GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $199K, a 39.1% decline from 2022.
  • GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $327K, a 51.6% decline from 2021.
  • GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $676K, a 204% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $199K -$128K -39.1% Oct 1, 2022 Sep 30, 2023 10-K 2024-01-19
2022 $327K -$348K -51.6% Oct 1, 2021 Sep 30, 2022 10-K 2024-01-19
2021 $676K +$453K +204% Oct 1, 2020 Sep 30, 2021 10-K 2023-01-09
2020 $223K -$46.5K -17.3% Oct 1, 2019 Sep 30, 2020 10-K 2022-01-05
2019 $269K +$10K +3.86% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-03
2018 $259K +$197K +318% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-31
2017 $62K Oct 1, 2016 Sep 30, 2017 10-K 2019-01-03
2014 $324K -$395K -54.9% Oct 1, 2013 Sep 30, 2014 10-K/A 2015-01-27
2013 $719K +$174K +31.9% Oct 1, 2012 Sep 30, 2013 10-K/A 2015-01-27
2012 $545K +$480K +732% Oct 1, 2011 Sep 30, 2012 10-K/A 2014-01-23
2011 $65.5K Oct 1, 2010 Sep 30, 2011 10-K/A 2013-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.